Edgar Filing: Leatt Corp

Leatt Corporation: Form 10-Q - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10−Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2014

[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________to _____________

Commission File No. 000-54693

LEATT CORPORATION
(Exact name of registrant as specified in its charter)

Nevada	20-2819367
(State or other jurisdiction of incorporation or	(I.R.S. Employer Identification No.)
organization)

50 Kiepersol Drive, Atlas Gardens, Contermanskloof Road,
Durbanville, Western Cape, South Africa, 7441
(Address of principal executive offices)

+(27) 21-557-7257
(Registrant’s telephone number, including area code)

__________________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [_]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X] No [_]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [_]	Accelerated filer [_]
Non-accelerated filer (Do not check if a smaller reporting company) [_]	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [_] No [X]

The number of shares outstanding of each of the issuer’s classes of common stock, as of November 10, 2014 is as follows:

Class of Securities	Shares Outstanding
Common Stock, $0.001 par value	5,200,623

LEATT CORPORATION

Quarterly Report on Form 10-Q
Three and Nine Months Ended September 30, 2014

TABLE OF CONTENTS

PART I		1
FINANCIAL INFORMATION		1
ITEM 1.	FINANCIAL STATEMENTS.	1
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	11
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	21
ITEM 4.	CONTROLS AND PROCEDURES.	21
PART II		21
OTHER INFORMATION		21
ITEM 1.	LEGAL PROCEEDINGS.	21
ITEM 1A.	RISK FACTORS.	22
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.	22
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES.	22
ITEM 4.	MINE SAFETY DISCLOSURES.	22
ITEM 5.	OTHER INFORMATION.	22
ITEM 6.	EXHIBITS.	23

PART I
FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

LEATT CORPORATION
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2014 AND 2013

	Page(s)
Financial Statements
Consolidated Balance Sheets	2
Consolidated Statements of Operations and Comprehensive Loss	3
Consolidated Statement of Changes in Stockholders' Equity	4
Consolidated Statements of Cash Flows	5
Notes to Consolidated Financial Statements	6 - 7

- 1 -

LEATT CORPORATION
CONSOLIDATED BALANCE SHEETS
ASSETS

		September 30, 2014			December 31, 2013
		Unaudited			Audited
Current Assets
Cash and cash equivalents	$	820,371		$	835,012
Short-term investments		58,147			58,130
Accounts receivable		1,464,776			3,139,273
Inventory		3,123,104			3,259,274
Payments in advance		395,239			144,302
Income tax refunds receivable		25,299			299
Deferred tax asset		110,000			110,000
Prepaid expenses and other current assets		382,117			1,092,450
Total current assets		6,379,053			8,638,740

Property and equipment, net		834,482			891,728

Other Assets
Other receivables		240,000			330,000
Deposits		16,893			19,469
Intangible assets		83,795			89,960
Total other assets		340,688			439,429

Total Assets	$	7,554,223		$	9,969,897

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
Accounts payable and accrued expenses	$	1,183,727		$	2,076,809
Short-term loan, net of finance charges		36,187			833,735
Total current liabilities		1,219,914			2,910,544

Deferred tax liabilities		40,300			40,680

Commitments and contingencies

Stockholders' Equity
Preferred stock, $.001 par value, 1,120,000 shares authorized, 120,000 shares issued and outstanding		3,000			3,000
Common stock, $.001 par value, 28,000,000 shares authorized, 5,200,623 shares issued and outstanding		130,008			130,008
Additional paid - in capital		7,309,942			7,307,515
Accumulated other comprehensive loss		(205,044	)		(111,864	)
Accumulated deficit		(943,897	)		(309,986	)
Total stockholders' equity		6,294,009			7,018,673

Total Liabilities and Stockholders' Equity	$	7,554,223		$	9,969,897

See accompanying notes to consolidated financial statements

- 2 -

LEATT CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
		Unaudited			Unaudited			Unaudited			Unaudited
Revenues	$	3,468,761		$	2,243,598		$	11,159,630		$	9,108,243

Cost of Revenues		1,584,460			1,071,522			5,070,624			4,555,276

Gross Profit		1,884,301			1,172,076			6,089,006			4,552,967

Product Royalty Income		65,083			105,328			136,346			285,014

Operating Expenses
Salaries and wages		547,955			508,641			1,651,178			1,640,282
Commissions and consulting expenses		134,692			142,866			441,943			426,035
Professional fees		209,168			197,672			823,690			1,013,783
Advertising and marketing		320,449			339,578			995,502			1,069,903
Office rent and expenses		61,807			62,528			183,792			195,342
Research and development costs		288,904			274,218			903,231			839,823
Bad debt expense		16,357			-			38,652			-
General and administrative expenses		565,004			518,537			1,611,242			1,619,221
Depreciation		67,075			60,585			214,583			252,040
Total operating expenses		2,211,411			2,104,625			6,863,813			7,056,429

Loss from Operations		(262,027	)		(827,221	)		(638,461	)		(2,218,448	)

Other Income (Expense)
Interest and other income (expense), net		(914	)		4,505			4,680			5,647
Total other income (expense)		(914	)		4,505			4,680			5,647

Loss Before Income Taxes		(262,941	)		(822,716	)		(633,781	)		(2,212,801	)

Income Taxes		250			(253,785	)		130			(252,865	)

Net Loss Available to Common Shareholders	$	(263,191	)	$	(568,931	)	$	(633,911	)	$	(1,959,936	)

Net Loss per Common Share
Basic	$	(0.05	)	$	(0.11	)	$	(0.12	)	$	(0.38	)
Diluted	$	(0.05	)	$	(0.11	)	$	(0.12	)	$	(0.38	)
Weighted Average Number of Common
Shares Outstanding
Basic		5,200,623			5,200,623			5,200,623			5,200,623
Diluted		5,200,623			5,200,623			5,200,623			5,200,623

Comprehensive Loss
Net Loss	$	(263,191	)	$	(568,931	)	$	(633,911	)	$	(1,959,936	)
Other comprehensive loss, net of $-0- deferred income taxes in 2014 and 2013
Foreign currency translation		(102,235	)		(7,271	)		(93,180	)		(223,805	)

Total Comprehensive Loss	$	(365,426	)	$	(576,202	)	$	(727,091	)	$	(2,183,741	)

See accompanying notes to consolidated financial statements

- 3 -

LEATT CORPORATION
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
AS OF AND FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2014

										Accumulated
										Other
	Preferred Stock A			Common Stock				Additional		Comprehensive			Accumulated
	Shares		Amount	Shares		Amount		Paid - In Capital		Income (Loss)			Deficit			Total

Balance, January 1, 2014	120,000	$	3,000	5,200,623	$	130,008	$	7,307,515	$	(111,864	)	$	(309,986	)	$	7,018,673

Compensation cost recognized in connection with stock options	-		-	-		-		2,427		-			-			2,427

Net loss	-		-	-		-		-		-			(633,911	)		(633,911	)

Foreign currency translation adjustment	-		-	-		-		-		(93,180	)		-			(93,180	)

Balance, September 30, 2014	120,000	$	3,000	5,200,623	$	130,008	$	7,309,942	$	(205,044	)	$	(943,897	)	$	6,294,009

See accompanying notes to consolidated financial statements

-4 -

LEATT CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2014 AND 2013

		2014			2013

Cash flows from operating activities
Net loss	$	(633,911	)	$	(1,959,936	)
Adjustments to reconcile net loss to net cash provided by
operating activities:
Depreciation		214,583			252,040
Deferred income taxes		(380	)		(254,870	)
Stock-based compensation		2,427			-
Bad debt		9,000			-
Inventory reserve		181,569			-
Gain on sale of property and equipment		(3,410	)		(2,844	)
(Increase) decrease in:
Accounts receivable		1,665,497			1,960,807
Inventory		(45,399	)		233,104
Payments in advance		(250,937	)		15,886
Prepaid expenses and other current assets		710,333			738,340
Income tax refunds receivable		(25,000	)		-
Other receivables		90,000			-
Deposits		2,576			22,361
Increase (decrease) in:
Accounts payable and accrued expenses		(893,082	)		(165,872	)
Income taxes payable		-			(1,499	)
Net cash provided by operating activities		1,023,866			837,517

Cash flows from investing activities
Capital expenditures		(199,469	)		(236,131	)
Proceeds from sale of property and equipment		6,699			2,844
Increase in short-term investments, net		(17	)		(311	)
Net cash used in investing activities		(192,787	)		(233,598	)

Cash flows from financing activities
Repayments of short-term loan, net		(797,548	)		(821,419	)
Net cash used in financing activities		(797,548	)		(821,419	)

Effect of exchange rates on cash and cash equivalents		(48,172	)		(80,224	)

Net decrease in cash and cash equivalents		(14,641	)		(297,724	)

Cash and cash equivalents - beginning		835,012			667,671
Cash and cash equivalents - ending	$	820,371		$	369,947

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	$	11,818		$	11,995
Cash paid for income taxes	$	130		$	2,419

Other noncash investing and financing activities
Common stock issued for services	$	2,427		$	-

See accompanying notes to consolidated financial statements

- 5 -

LEATT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1 - Basis of presentation

The consolidated balance sheet as of December 31, 2013 was audited and appears in the Form 10-K filed by the Company with the Securities and Exchange Commission on March 19, 2014. The consolidated balance sheet as of September 30, 2014 and the consolidated statements of operations and comprehensive loss for the three months and nine months ended September 30, 2014 and 2013, changes in stockholders’ equity for the nine months ended September 30, 2014, cash flows for the nine months ended September 30, 2014 and 2013, and the related information contained in these notes have been prepared by management without audit. In the opinion of management, all adjustments (which include only normal recurring items) necessary to present fairly the financial position, results of operations and cash flows in conformity with generally accepted accounting principles as of September 30, 2014 and for all periods presented have been made. Interim operating results are not necessarily indicative of operating results for a full year.

Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. While management of the Company believes that the disclosures presented are adequate to make the information not misleading, it is suggested that these condensed consolidated financial statements be read in conjunction with the audited financial statements and notes thereto for the year ended December 31, 2013 as filed with the Securities and Exchange Commission in the Company’s Form 10-K.

Note 2 - Inventory

Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out (FIFO) method. Inventory consists primarily of finished goods. Shipping and handling costs are included in the cost of inventory. In assessing the inventory value, the Company must make estimates and judgments regarding reserves required for product obsolescence, aging of inventory and other issues potentially affecting the saleable condition of products. In performing such evaluations, the Company utilizes historical experience as well as current market information. The reserve for obsolescence for the nine months ended September 30, 2014 and 2013 was $313,224 and $0, respectively.

Note 3 - Intangible Assets

The Company’s intangible assets consist of acquired patents with an indefinite useful life and are thus not amortized. Intangible assets are carried at cost less impairment. Amortization expense for the nine months ended September 30, 2014 was zero. There was no impairment of intangible assets at September 30, 2014.

Note 4 - Short-term Loan

The Company carries two product liability insurance policies – one with a U.S. insurance carrier and a second with a South African insurance carrier. The Company finances payment of its short-term insurance premiums over the period of coverage, which is generally twelve months. The US short-term loan is payable in monthly installments of $68,274 over an 11 month period at an APR of 2.647% and the South African short-term loan is payable in monthly installments of $1,839 over a 10 month period at a flat interest rate of 3.50% .

The Company carries directors and officers liability insurance. The Company finances payment of its short-term insurance premiums over the period of coverage, which is generally twelve months. The short-term loan is payable in eleven payments of $4,997 at a 2.647% annual interest rate.

Note 5- Income Taxes

The Company uses the asset and liability approach to account for income taxes. Deferred tax assets and liabilities are determined based on the differences between the financial statement carrying amounts and the income tax basis of assets and liabilities. A valuation allowance is applied against any net deferred tax asset if, based on available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The provision for income taxes included taxes currently payable, if any, plus the net change during the period in deferred tax assets and liabilities recorded by the Company.

The Company applies the provisions of FASB ASC Topic 740-10, Accounting for Uncertainty in Income Taxes (“Standard”), which provides that the tax effects from an uncertain tax position can be recognized in the consolidated financial statements only if the position is more likely than not of being sustained upon an examination by tax authorities. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, the standard provides guidance on derecognition, classification, interest and penalties; accounting in interim periods, disclosure and transition, and any amounts when incurred would be recorded under these provisions.

- 9 -

The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. As of September 30, 2014, the Company has no unrecognized tax benefits. The Company’s 2011 income tax return is under examination by the Internal Revenue Service.

Note 6 - Net Income Per Share of Common Stock

Basic net income per common share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted–average number of common stock shares and dilutive potential common shares outstanding during the period. For the three months and nine months ended September 30, 2014, the Company had 410,200 potential common shares, consisting of 120,000 preferred shares and options to purchase 290,200 shares, outstanding that were anti-dilutive and therefore not included in diluted net income per share.

Note 7 - Litigation

In the ordinary course of business, the Company is involved in various legal proceedings involving product liability and personal injury and intellectual property litigation. The Company is insured against loss for certain of these matters. The Company will record contingent liabilities resulting from asserted and unasserted claims against it when it is probable that the liability has been incurred and the amount of the loss is reasonably estimable. The Company will disclose contingent liabilities when there is a reasonable possibility that the ultimate loss will exceed the recorded liability. While the outcome of currently pending litigation is not yet determinable, the ultimate exposure with respect to these matters cannot be ascertained. However, based on the information currently available to the Company, the Company does not expect that any liabilities or costs that might be incurred to resolve these matters will have a material adverse effect on the financial condition, results of operations, liquidity or cash flows of the Company.

Note 8 – Subsequent Events

The company has evaluated all subsequent events through the date the financial statements were released.

- 10 -

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Special Note Regarding Forward Looking Statements

This report contains forward-looking statements that are contained principally in the sections entitled “Our Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the factors described in the section captioned “Risk Factors” in our latest annual report on Form 10-K filed with the SEC. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “would” and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements include, among other things, statements relating to:

our expectations regarding growth in the motor sports market;
our expectation regarding increasing demand for protective equipment used in the motor sports market;
our belief that we will be able to effectively compete with our competitors and increase our market share;
our expectations with respect to increased revenue growth and our ability to achieve profitability resulting from increases in our production volumes; and
our future business development, results of operations and financial condition.

Also, forward-looking statements represent our estimates and assumptions only as of the date of this quarterly report. You should read this quarterly report and the documents that we reference and filed as exhibits to the quarterly report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

Use of Certain Defined Terms

Except as otherwise indicated by the context, references in this quarterly report to:

“Leatt,” “we,” “us,” “our,” the “Registrant” or the “Company” are to the combined business of Leatt Corporation, a Nevada corporation, its South African branch, Leatt SA, and its direct, wholly-owned subsidiaries, Two Eleven, Leatt New Zealand and Three Eleven;
“Leatt SA” are to the Company’s branch office known as ‘Leatt Corporation (Incorporated in the State of Nevada)’ incorporated under the laws of South Africa with registration number: 2007/032780/10;
“Leatt USA” are to Leatt USA, LLC, a Nevada Limited Liability Company;
“Leatt New Zealand” are to Leatt New Zealand Limited, a New Zealand Company;
“NZD” are to the legal currency of New Zealand. For all NZD amounts reported, the dollar amount has been calculated on the basis that $1=NZD1.28434 for its September 30, 2014 unaudited balance sheet.
“PRC”, and “China” are to the People’s Republic of China;
“Two Eleven” refers to Two Eleven Distribution, LLC, a California limited liability company;
“Three Eleven” are to Three Eleven Distribution (Pty) Limited, a South African Company;
“Securities Act” are to the Securities Act of 1933, as amended, and to “Exchange Act” are to Securities Exchange Act of 1934, as amended;
“South Africa” are to the Republic of South Africa;
“U.S. dollar,” “$” and “US$” are to the legal currency of the United States.
“Xceed Holdings” refers to Xceed Holdings cc., a close corporation incorporated under the laws of South Africa, and wholly-owned by The Leatt Family Trust, of which Dr. Christopher J. Leatt, the Company’s chairman, is a Trustee and Beneficiary; and
“ZAR” refers to the South African Rand, the legal currency of South Africa. For all ZAR dollar amounts reported, the dollar amount has been calculated on the basis that $1 = ZAR11.2594 for its September 30, 2014 unaudited balance sheet.

- 11 -

Overview

Leatt designs, develops, markets and distributes personal protective equipment for participants in all forms of motor sports and leisure activities, including riders of motorcycles, bicycles, snowmobiles and ATVs, as well as racing car drivers. The Company sells its products to customers worldwide through a global network of distributors and retailers. Leatt also acts as the original equipment manufacturer for neck braces sold by other international brands.

The Company’s flagship products are based on the Leatt-Brace® system, a patented injection molded neck protection system owned by Xceed Holdings, designed to prevent potentially devastating injuries to the cervical spine and neck. The Company has the exclusive global manufacturing, distribution, sale and use rights to the Leatt-Brace®, pursuant to a license agreement between the Company and Xceed Holdings, a company owned and controlled by the Company’s Chairman and founder, Dr. Christopher Leatt. The Company also has the right to use apparatus embodying, employing and containing the Leatt-Brace® technology and has designed, developed, marketed and distributed other personal protective equipment using this technology, as well as its own developed technology, including the Company’s new body protection products which it markets under the Leatt Protection Range brand.

The Company’s research and development efforts are conducted at its research facilities, located at its executive headquarters in Cape Town, South Africa. The Company employs 5 full-time employees who are dedicated exclusively to research, development, and testing. The Company also utilizes consultants, academic institutions and engineering companies as independent contractors or consultants, from time to time, to assist it with its research and development efforts. Leatt products have been tested and reviewed internally and by external bodies. All Leatt products are compliant with applicable European Union directives, or CE certified, where appropriate. Certain products, such as the Moto R, have been certified by SFI Foundation (USA) and the Moto GPX was tested by BMW Motorrad (Germany) and reviewed by KTM (Austria). The Company is also in discussions with governing and racing bodies, such as the Fédération Internationale de l'Automobile (FIA), the Fédération Internationale de Motocyclisme (FIM) and the National Association for Stock Car Auto Racing (NASCAR), to have the Leatt-Brace® accredited by these bodies.

Our products are manufactured in China under outsource manufacturing arrangements with third-party manufacturers located there. The Company utilizes outside consultants and its own employees to ensure the quality of its products through regular on-site product inspections. Products purchased through international sales are usually shipped directly from our manufacturers’ warehouses or points of dispatch to customers or their import agents.

Leatt earns revenues through the sale of its products through approximately 60 distributors worldwide, who in turn sell its products to retailers. Leatt distributors are required to follow certain standard business terms and guidelines for the sale and distribution of Leatt products. Two Eleven and Leatt SA directly distribute Leatt products to retailers in the United States and South Africa, respectively.

Principal Factors Affecting Our Financial Performance

We believe that the following factors will continue to affect our financial performance:

Global Economic Fragility – The ongoing turmoil in the global economy, especially in the U.S. and Europe, may have an impact on our business and our financial condition, and we may face challenges if economic conditions do not improve. These economic conditions impact levels of consumer spending, which have deteriorated and may remain depressed for the foreseeable future. If demand for our products fluctuates as a result of these economic conditions or otherwise, our revenue and gross margin could be harmed.
Fuel Prices – Significant fluctuations in fuel prices could have both a positive and negative effect on our business and operations. A significant portion of our revenue is derived from international sales and significant fluctuations in world fuel prices could significantly increase the price of shipping or transporting our products which we may not be able to pass on to our customers. On the other hand, fluctuations in fuel prices lead to higher commuter costs which may encourage the increased use of motorcycles and bicycles as alternative modes of transportation and lead to an increase in the market for our protection products.
Product Liability Litigation – We face an inherent business risk of exposure to product liability claims arising from the claimed failure of our products to help prevent the types of personal injury or death against which they are designed to help protect. Therefore we have acquired very costly product liability insurance worldwide. We have not experienced any material uninsured losses due to product liability claims, but it is possible that we could experience material losses in the future. After a two-week trial in the United States District Court for the Northern District of Ohio (Eastern) ending on April 17, 2014, a federal jury returned a defense verdict for the Company in the first Leatt-Brace® product liability lawsuit to be tried in the United States. The plaintiffs in that case had alleged that defective product design and failure to warn had caused a then fifteen year-old motocross rider, to suffer multiple mid-thoracic spine fractures, causing immediate and permanent paraplegia, when he crashed at a relatively low speed on February 13, 2011. When the accident occurred, he was wearing a helmet and other safety gear from several different companies, including the Company's acclaimed Leatt-Brace®. The Company produced evidence at trial showing that his thoracic paraplegia was an unavoidable consequence of his fall, not the result of wearing a Leatt-Brace®, and that the neck brace likely saved his life (or saved him from quadriplegia) by preventing cervical spine injury. The Company had maintained from the onset that this and a small handful of other lawsuits are without merit and that it will vigorously defend itself in each case. Although we carry product liability insurance, a successful claim brought against us could significantly harm our business and financial condition and have an adverse impact on our ability to renew our product liability insurance or secure new coverage.

- 12 -

Protection of Intellectual Property – We believe that the continued success of our business is dependent on our intellectual property portfolio consisting of globally registered trademarks, design patents and utility patents related to the Leatt-Brace®. We believe that a loss of these rights would harm or cause a material disruption to our business and, our corporate strategy is to aggressively take legal action against any violators of our intellectual property rights, regardless of where they may be. From time to time, we have had to enforce our intellectual property rights through litigation and we may be required to do so in the future. Such litigation may result in substantial costs and could divert resources and management attention from the operations of our business.

Results of Operations

The following summary of our results of operations should be read in conjunction with our financial statements and the notes thereto for the three-month and nine-month periods ended September 30, 2014 and 2013 included herein. The following tables set forth key components of our results of operations for the periods indicated, both in dollars and as a percentage of sales revenue and key components of our revenue for the periods indicated in dollars and percentages.

Three Months Ended September 30, 2014 compared to the Three Months Ended September 30, 2013

The following table summarizes the results of our operations during the three-month periods ended September 30, 2014 and 2013 and provides information regarding the dollar and percentage increase or (decrease) in such periods:

										Percentage
		Three Months Ended September 30,						$ Increase		Increase
Item		2014			2013			(Decrease)		(Decrease)

REVENUES	$	3,468,761		$	2,243,598		$	1,225,163		55%
COST OF REVENUES		1,584,460			1,071,522		$	512,938		48%
GROSS PROFIT		1,884,301			1,172,076		$	712,225		61%
PRODUCT ROYALTY INCOME		65,083			105,328		$	(40,245	)	-38%
OPERATING EXPENSES
Salaries and Wages		547,955			508,641		$	39,314		8%
Commissions and Consulting		134,692			142,866		$	(8,174	)	-6%
Professional Fees		209,168			197,672		$	11,496		6%
Advertising and Marketing		320,449			339,578		$	(19,129	)	-6%
Office Rent and Expenses		61,807			62,528		$	(721	)	-1%
Research and Development Costs		288,904			274,218		$	14,686		5%
General and Administrative		565,004			518,537		$	46,467		9%
Bad debt expense		16,357			-		$	16,357		100%
Depreciation		67,075			60,585		$	6,490		11%
Total Operating Expenses		2,211,411			2,104,625		$	106,786		5%
LOSS FROM OPERATIONS		(262,027	)		(827,221	)	$	565,194		68%
Other Income (Expense)		(914	)		4,505		$	(5,419	)	-120%
LOSS BEFORE INCOME TAXES		(262,941	)		(822,716	)	$	559,775		68%
Income Taxes		250			(253,785	)	$	254,035		100%
NET LOSS	$	(263,191	)	$	(568,931	)	$	305,740		54%

- 13 -

Revenues – We earn revenues from the sale of our protective gear comprising of Neck Braces, Body Armor and Other Products, Parts and Accessories both in the United States and internationally. For the three months ended September 30, 2014 and 2013, revenues associated with international customers were $2.13 million and $1.18 million, or 61% and 53% of revenues, respectively. Revenues for the three months ended September 30, 2014 were $3.47 million, a 55% increase, compared to revenues of $2.24 million for the quarter ended September 30, 2013. This increase in revenues is attributable to a $0.30 million increase in Neck Brace sales, as well as a $1.0 million increase in Body Armor sales.

The following table sets forth our revenues by product line for the three months ended September 30, 2014 and 2013:

			Three Months Ended September 30,
		2014	% of		2013	% of
			Revenues			Revenues
Neck Braces	$	1,618,544	47%	$	1,321,626	59%
Body Armor	$	1,716,500	49%	$	719,929	32%
Other Products, Parts and Accessories	$	133,717	4%	$	202,043	9%
	$	3,468,761	100%	$	2,243,598	100%

Sales of our flagship Neck Brace accounted for $1.62 million and $1.32 million, or 47% and 59% of our revenues for the quarters ended September 30, 2014 and 2013, respectively. The 23% increase in Neck Brace revenues in the United States is primarily attributable to increased demand for the Company’s Neck Brace products as a result of the introduction of the Fusion 2.0 Junior and 5.5 Neck Brace product lines in the United States and abroad.

Our Body Armor products are comprised of chest protectors, full upper body protectors, upper body protection vests, back protectors, knee braces and knee and elbow guards. Body Armor sales accounted for $1.72 million and $0.72 million or 49% and 32% of our revenues for the quarters ended September 30, 2014 and 2013, respectively. The 139% increase in Body Armor revenues was primarily the result of successful market acceptance of our new C Frame Knee Brace which was introduced during the 2014 period.

Our Other Products, Parts and Accessories are comprised of aftermarket support items required primarily to replace worn or damaged parts through our global distribution network as well as clothing, outerwear and accessories that include hats, jackets, bags, hydration kits and cooling garments. Other Products, Parts and Accessories sales accounted for $0.1 million and $0.2 million or 4% and 9% of our revenues for the quarters ended September 30, 2014 and 2013, respectively. The decrease in our Other Products, Parts and Accessories is primarily due to a 62% decrease in the volume of hydration units sold internationally during the period.

Cost of Revenues and Gross Profit – Cost of revenues for the quarters ended September 30, 2014 and 2013 were $1.6 million and $1.1 million, respectively. Gross Profit for the quarters ended September 30, 2014 and 2013 were $1.9 million and $1.2 million, respectively, or 54% and 52% of revenues respectively. The increase in gross profit margin was primarily due to increased Neck Brace sales in the United States and abroad, as well as improved Body Armor margins as a result of the introduction of the C Frame Knee Guard during the 2014 period. While our Body Armor products continue to generate a lower gross margin than do Neck Brace products, they represented 49% of the total Company sales in the third quarter of 2014, as compared to only 32% in the third quarter of 2013.

Product Royalty Income – Product royalty income is earned on sales to distributors that have royalty agreements in place, as well as sales of licensed products by third parties that have licensing agreements in place. Product royalty income for the quarters ended September 30, 2014 and 2013 were $65,083 and $105,328, respectively. The 38% decrease in product royalty income is due to a decrease in the sale of licensed products by licensees in the 2014 period.

Salaries and Wages – Salaries and wages for the quarters ended September 30, 2014 and 2013 were $547,955 and $508,641, respectively. This 8% increase in salaries and wages during the 2014 period was primarily due to the employment of additional US sales management and European brand management staff.

- 14 -

Commissions and Consulting Expense – During the quarters ended September 30, 2014 and 2013, commissions and consulting expenses were $134,692 and $142,866, respectively. This 6% decrease in commissions and consulting expenses is primarily due to the restructuring of remuneration packages for US sales staff.

Professional Fees – Professional fees consist of costs incurred for audit, tax and regulatory filings, as well as patent protection and product liability litigation expenses incurred as the Company continues to expand. Professional fees for the quarters ended September 30, 2014 and 2013 were $209,168 and $197,672, respectively. This 6% increase in professional fees is primarily due to increased spending on product liability litigation during the 2014 period.

Advertising and Marketing – The Company places paid advertising in various motorsport magazines and online media, and sponsors a number of events, teams and individuals to increase product and brand visibility. Advertising and marketing expenses for the quarters ended September 30, 2014 and 2013 were $320,449 and $339,578, respectively. The 6% decrease in advertising and marketing expenditures during the 2014 period is primarily due to the Company’s continued expansion of more cost effective online marketing campaigns that reach a wider audience than the print campaigns previously utilized by the Company.

Office Rent and Expenses – Office rent and expenses for the quarters ended September 30, 2014 and 2013 remained flat at $61,807 and $62,528, respectively.

Research and Development Costs – These costs consists of the salaries of staff members that are directly involved in the research and development of innovative products, as well as the direct costs associated with developing these products. Research and development costs for the quarters ended September 30, 2014 and 2013, increased to $288,904, from $274,218, during the same 2013 quarter. The 5% increase in research and development costs is a result of direct costs incurred in the continued development of the Company’s widening range of innovative products.

General and Administrative Expenses – General and administrative expenses consists of insurance, travel, merchant fees, telephone, office and computer supplies. General and administrative expenses for the quarters ended September 30, 2014 and 2013 were $565,004 and $518,537, respectively. The 9% increase in general and administrative expenses is primarily as a result of increased travel expenditures incurred by the Company’s research and development staff during the 2014 period.

Bad Debt Expense – Bad Debt Expense for the quarters ended September 30, 2014 and 2013 were $16,357 and $0, respectively. This 100% increase in Bad Debt Expense is primarily the result of the write off of a portion of unrecoverable debt owing to Two Eleven.

Depreciation Expense – Depreciation Expense for the quarters ended September 30, 2014 and 2013 were $67,075 and $60,585, respectively. This 11% increase in depreciation is primarily as a result of the addition of molds and tooling required for the production of the Company’s widening product range.

Total Operating Expenses – Total operating expenses increased by $106,786, to $2,211,411 in the three months ended September 30, 2014, or 5%, compared to $2,104,625 in the 2013 period. This increase is primarily due to the increased salaries, wages and general administrative expenditures discussed above.

Net loss – The net loss after income taxes for the quarter ended September 30, 2014 was $263,191 as opposed to net loss after income taxes of $568,931 for the quarter ended September 30, 2013. This decrease in net loss is primarily due to increased revenues and decreased cost of revenues that were partially offset by increased operating costs discussed above.

Nine Months Ended September 30, 2014, compared to the Nine Months Ended September 30, 2013

The following table summarizes the results of our operations during the nine-month periods ended September 30, 2014 and 2013 and provides information regarding the dollar and percentage increase or (decrease) in such periods:

- 15 -

										Percentage
		Nine Months Ended September 30,						$ Increase		Increase
Item		2014			2013			(Decrease)		(Decrease)

REVENUES	$	11,159,630		$	9,108,243		$	2,051,387		23%
COST OF REVENUES		5,070,624			4,555,276		$	515,348		11%
GROSS PROFIT		6,089,006			4,552,967		$	1,536,039		34%
PRODUCT ROYALTY INCOME		136,346			285,014		$	(148,668	)	-52%
OPERATING EXPENSES
Salaries and Wages		1,651,178			1,640,282		$	10,896		1%
Commissions and Consulting		441,943			426,035		$	15,908		4%
Professional Fees		823,690			1,013,783		$	(190,093	)	-19%
Advertising and Marketing		995,502			1,069,903		$	(74,401	)	-7%
Office Rent and Expenses		183,792			195,342		$	(11,550	)	-6%
Research and Development Costs		903,231			839,823		$	63,408		8%
General and Administrative		1,611,242			1,619,221		$	(7,979	)	0%
Bad debt expense		38,652			-		$	38,652		100%
Depreciation		214,583			252,040		$	(37,457	)	-15%
Total Operating Expenses		6,863,813			7,056,429		$	(192,616	)	-3%
LOSS FROM OPERATIONS		(638,461	)		(2,218,448	)	$	1,579,987		71%
Other Income		4,680			5,647		$	(967	)	-17%
LOSS BEFORE INCOME TAXES		(633,781	)		(2,212,801	)	$	1,579,020		71%
Income Taxes		130			(252,865	)	$	252,995		100%
NET LOSS	$	(633,911	)	$	(1,959,936	)	$	1,326,025		68%

Revenues – Revenues for the nine months ended September 30, 2014 were $11.16 million, a 23% increase, compared to revenues of $9.11 million for the nine-month period ended September 30, 2013. Revenues associated with international customers were $6.46 million and $5.13 million, or 58% and 56% of revenues, respectively, for the 2014 and 2013 periods. The overall increase in revenues is attributable to a $1.25 million increase in Neck Brace sales, as well as a $0.87 million increase in Body Armor sales during the 2014 period.

The following table sets forth our revenues by product line for the nine months ended September 30, 2014 and 2013:

		Nine Months Ended September 30,
		2014	% of		2013	% of
			Revenues			Revenues
Neck Braces	$	6,123,098	55%	$	4,873,332	54%
Body Armor	$	4,507,136	40%	$	3,635,921	40%
Other Products, Parts and Accessories	$	529,396	5%	$	598,990	6%
	$	11,159,630	100%	$	9,108,243	100%

Sales of our flagship Neck Brace accounted for $6.1 million and $4.9 million, or 55% and 54% of our revenues for the nine-month periods ended September 30, 2014 and 2013, respectively. The 26% increase in Neck Brace revenues in the United States is primarily a result of the successful market acceptance of the Fusion 2.0 Junior and 5.5 Neck Brace in the United States and abroad. Neck Brace revenues were also higher in the 2014 period due to the sale of newly released products at full value, as compared to the sale of older Brace products at lower close out prices in the prior year period.

Body Armor sales accounted for $4.5 million and $3.6 million, or 40% and 40% of our revenues for the nine-month periods ended September 30, 2014 and 2013, respectively. The 24% increase in Body Armor revenues was primarily due to the successful acceptance of the Company’s new C Frame Knee Brace internationally.

Other Products, Parts and Accessories sales accounted for $0.53 million and $0.59 million, or 5% and 6% of our revenues for the nine-month periods ended September 30, 2014 and 2013, respectively. The decrease in our Other Products, Parts and Accessories is primarily due to a 31% decrease in the volume of hydration units sold during the period, when compared to the prior year period.

Cost of Revenues and Gross Profit – Cost of revenues for the nine-month periods ended September 30, 2014 and 2013 were $5.1 million and $4.6 million, respectively. Gross Profit for the nine-month periods ended September 30, 2014 and 2013 were $6.1 million and $4.6 million, respectively, or 55% and 50% of revenues respectively. The increase in gross profit margin was primarily due to increased Neck Brace sales in the United States and abroad, as well as improved Body Armor margins as a result of the introduction of the C Frame Knee Brace. Our Body Armor products continue to generate a lower gross margin than do Neck Brace products.

- 16 -

Product Royalty Income – Product royalty income for the nine months ended September 30, 2014 and 2013 were $136,346 and $285,014, respectively. The 52% decrease in product royalty income is due to a decrease in the sale of licensed products by licensees in the 2014 period.

Salaries and Wages – Salaries and wages for the nine-month periods ended September 30, 2014 and 2013 were $1,651,178 and $1,640,282, respectively. This 1% increase in salaries and wages is primarily due to the employment of new US sales management staff, as well as the restructuring of remuneration packages for US sales staff.

Commissions and Consulting Expense – During the nine-month periods ended September 30, 2014 and 2013, commissions and consulting expenses were $441,943 and $426,035, respectively. This 4% increase in commissions and consulting expenses is primarily due to increased commissions payable to the Company’s European sales staff, compared to the prior period.

Professional Fees – Professional fees for the nine-month periods ended September 30, 2014 and 2013 were $823,690 and $1,013,783, respectively. This 19% decrease in professional fees during the 2014 period is primarily due to decreased spending on patent litigation during the 2014 period. The Company settled various patent infringement suits during the period ended December 31, 2013.

Advertising and Marketing – Advertising and marketing expenses for the nine-month periods ended September 30, 2014 and 2013 were $995,502 and $1,069,903, respectively. The 7% decrease in advertising and marketing expenditures during the 2014 period is primarily due to the Company’s continued focus on more cost effective online and digital campaigns that reach a wider audience than the print campaigns previously utilized by the Company.

Office Rent and Expenses – Office rent and expenses for the nine-month periods ended September 30, 2014 and 2013 were $183,792 and $195,342, respectively. The 6% decrease in office rent and expenses is primarily the result of the consolidation of offsite additional warehouse space that was previously occupied by Two Eleven.

Research and Development Costs – Research and development costs for the nine-month periods ended September 30, 2014 and 2013, increased to $903,231, from $839,823, respectively. The 8% increase in research and development costs is a result of development costs incurred to widen the Company’s range of innovative protective gear.

Bad Debt Expense – Bad Debt Expense for the nine-month periods ended September 30, 2014 and 2013 were $38,652 and $0, respectively. This 100% increase in Bad Debt Expense is due to the write off of debt owing by US customers that were deemed to be irrecoverable.

General and Administrative Expenses – General and administrative expenses for the nine-month periods ended September 30, 2014 and 2013 were $1,611,242 and $1,619,221, respectively. The 0.5% decrease in general and administrative expenses is primarily as a result of decreased expenditures on telecommunication costs.

Depreciation Expense – Depreciation Expense for the nine-month periods ended September 30, 2014 and 2013 were $214,583 and $252,040, respectively. This 15% decrease in depreciation is primarily as a result of various assets being fully depreciated for the period having reached the end of their economic useful lives.

Total Operating Expenses – Total operating expenses decreased by $192,616 to $6,863,813 in the nine months ended September 30, 2014, or 3%, compared to $7,056,429 in the 2013 period. This decrease is primarily due to decreased spending of professional fees relating to patent litigation discussed above.

Net loss –The net loss after income taxes for the nine-month period ended September 30, 2014 was $633,911, as compared to net loss after income taxes of $1,959,936 for the same 2013 period. This decrease in net loss is primarily due to increased revenues and decreased cost of revenues, as well as decreased operating expenses discussed above.

- 17 -

Liquidity and Capital Resources

At September 30, 2014, we had cash and cash equivalents of $0.8 million and $0.06 million of short-term investments. The following table sets forth a summary of our cash flows for the periods indicated:

		September 30,
		2014			2013
Net cash provided by operating activities	$	1,023,866		$	837,517
Net cash used in investing activities	$	(192,787	)	$	(233,598	)
Net cash used in financing activities	$	(797,548	)	$	(821,419	)
Effect of exchange rate changes on cash and cash equivalents	$	(48,172	)	$	(80,224	)
Net (decrease) in cash and cash equivalents	$	(14,641	)	$	(297,724	)
Cash and cash equivalents at the beginning of period	$	835,012		$	667,671
Cash and cash equivalents at the end of period	$	820,371		$	369,947

Cash decreased by $14,641, or 2%, for the nine months ended September 30, 2014. The primary sources of cash for the nine months ended September 30, 2014 were decreased accounts receivables of $1,665,497, and decreased prepaid expenses and other current assets of $710,333. The primary uses of cash for the nine months ended September 30, 2014 was a net loss of $633,911, decreased accounts payable and accrued expenses of $893,082 and the repayment of a short-term loan amounting to $797,548. As of September 30, 2014, we did not have any credit facilities or significant amounts owed to third party lenders.

The Company is currently meeting its working capital needs through cash on hand as well as internally generated cash from operations. Management believes that its current cash and cash equivalent balances, along with the net cash generated by operations are sufficient to meet its anticipated operating cash requirements for at least the next twelve months. There are currently no plans for any major capital expenditures in the next twelve months. Our long-term financing requirements depend on our growth strategy, which relates primarily to our desire to increase revenue both domestically as well as internationally.

Obligations under Material Contracts

Pursuant to our Licensing Agreement with Xceed Holdings, a company owned and controlled by Dr. Christopher Leatt, our founder, chairman and head of research and development, we pay Xceed Holdings, 4% of all Neck Brace sales revenue billed and received by the Company on a quarterly basis, based on sales of the previous quarter. In addition, pursuant to a separate license agreement between the Company and Mr. J. P. De Villiers, our former director, the Company is obligated to pay a royalty fee of 1% of all our billed and received Neck Brace sales revenue, in quarterly installments, based on sales of the previous quarter, to a trust that is beneficially owned and controlled by Mr. De Villiers.

Pursuant to a Premium Finance Agreement, dated October 11, 2013, between the Company and AFCO Acceptance Corporation “AFCO,” the company was obligated to pay AFCO an aggregate sum of $1,001,151 in eleven payments of $91,014, at a 2.647% annual interest rate, commencing on November 1, 2013 and ending on September 1, 2014. As of September 30, 2014, the Company had repaid AFCO the entire balance due under the Premium Finance Agreement, and had entered into a new premium financing agreement, dated October 7, 2014, with them. Pursuant to the new agreement, the Company is obligated to pay AFCO an aggregate sum of $741,165 in eleven payments of $68,273, at an annual interest rate of 2.647%, commencing on November 1, 2014 and ending on September 1, 2015. Any late payment during the term of the agreement will be assessed a late penalty of 5% of the payment amount due, and in the event of default AFCO has the right to accelerate the payment due under the agreement.

Pursuant to a Premium Finance Agreement, dated June 9, 2014, between the Company and AFCO, the company is obligated to pay AFCO an aggregate sum of $59,244 in eleven payments of $4,997 at a 2.647% annual interest rate, commencing on June 1, 2014 and ending on April 1, 2015. Any late payment during the term of the agreement will be assessed a late penalty of 5% of the payment amount due, and in the event of default AFCO has the right to accelerate the payment due under the agreement. As of September 30, 2014, the Company had not defaulted on its payment obligations under this agreement.

- 18 -

Critical Accounting Policies and Estimates

Our discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenues and expenses during the reporting period.

There have been no material changes in our critical accounting policies or critical accounting estimates since December 31, 2013. We have not adopted any accounting policies since December 31, 2013 that have or will have a material impact on our consolidated financial statements. For further discussion of our accounting policies see the “Summary of Significant Accounting Policies” in the Notes to Consolidated Financial Statements, as of and for the year ended December 31, 2013 included in our annual report on Form 10-K filed for the period, as well as the notes in this Form 10-Q.

We have identified the following as the items that require the most significant judgment and often involve complex estimation: revenue recognition, estimating allowances for doubtful accounts receivable, inventory valuation, impairment of long-lived assets and accounting for income taxes.

Revenue and Cost Recognition - All manufacturing of Leatt products is performed by third party subcontractors in China. The Company's products are sold worldwide to a global network of distributors and dealers, and directly to consumers when there are no dealers or distributors in their geographic area (collectively the "customers"). Revenues from product sales are recognized when earned, net of applicable provisions for discounts and returns and allowances in the event of product defect. Revenue is considered to be realized or realizable and earned when all of the following criteria are met: title and risk of loss have passed to the customer, persuasive evidence of an arrangement exists, delivery has occurred, the price is fixed and determinable and collectability is reasonably assured. Our distributor payment terms range from pre-payment in full to 60 days after shipment and subsequent sales of our products by distributors have no effect on the amount and timing of payments due to us. Furthermore, products purchased by distributors may not be returned to us in the event that any such distributor relationship is terminated.

Since the Company (through its wholly owned subsidiary) serves as the distributor of Leatt products in the United States, the Company records its revenue and related cost of revenue for its product sales in the United States upon shipment of the merchandise to the dealer or to the ultimate consumer when there is no dealer in the geographic area and the sales order was received directly from, and paid by, the ultimate consumer. Since the Company (through its South African branch) serves as the distributor of Leatt products in South Africa, the Company records its revenue and related cost of revenue for its product sales in South Africa upon shipment of the merchandise from the branch to the dealer. International sales (other than in South Africa) are generally drop-shipped directly from the third party manufacturer to the international distributors.

Revenue and related cost of revenue is recognized at the time of shipment from the manufacturer's port when the shipping terms are Free On Board ("FOB") shipping point, Cost and Freight ("CFR") or Cost and Insurance to named place ("CIP") as legal title and risk of loss to the product pass to the distributor. Sales to all customers (distributors, dealers and consumers) are generally final; however, in limited instances, product may be returned due to product quality issues. Historically, returns due to product quality issues have not been material and there have been no distributor terminations that resulted in product returns. Cost of revenues also includes royalty fees associated with sales of Leatt-Brace products.

Product royalty income is recorded as the underlying product sales occur, in accordance with the related licensing arrangements.

Allowance for Doubtful Accounts Receivable – Accounts receivable consist of amounts due to the Company from normal business activities. Credit is granted to substantially all distributors on an unsecured basis. We continuously monitor collections and payments from customers and maintain an allowance for doubtful accounts receivable based upon historical experience and any specific customer collection issues that have been identified. In determining the amount of the allowance, we are required to make certain estimates and assumptions. Accounts receivable balances that are still outstanding after we have used reasonable collection efforts are written off as uncollectible. While such credit losses have historically been minimal, within our expectations and the provisions established, we cannot guarantee that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of any of our significant customers could have a material adverse effect on the collectability of our accounts receivable and our future operating results.

Inventory Valuation – Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out (FIFO) method. Inventory consists primarily of finished goods. Shipping and handling costs are included in the cost of inventory. In assessing the inventory value, we make estimates and judgments regarding reserves required for product obsolescence, aging of inventory and other issues potentially affecting the saleable condition of products. In performing such evaluations, we utilize historical experience as well as current market information. The reserve for obsolescence was $313,224 and $0 as of September 30, 2014 and 2013, respectively. The addition to the reserve was $16,404 and $0 for the quarters ended September 30, 2014 and 2013, respectively.

- 19 -

Impairment of Long-Lived Assets – Our long-lived assets include property and equipment. We evaluate our long-lived assets for recoverability whenever events or changes in circumstances indicate that an asset may be impaired. In evaluating an asset for recoverability, we estimate the future cash flow expected to result from the use of the asset and eventual disposition. If the expected future undiscounted cash flow is less than the carrying amount of the asset, an impairment loss, equal to the excess of the carrying amount over the fair value of the asset, is recognized. We have determined there was no impairment charge during the quarters ended September 30, 2014 and 2013.

Income Taxes – As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax provision (benefit) in each of the jurisdictions in which we operate. This process involves estimating our current income tax provision (benefit) together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheets. We regularly evaluate our ability to recover the reported amount of our deferred income taxes considering several factors, including our estimate of the likelihood of the Company generating sufficient taxable income in future years during the period over which the temporary differences reverse.

Recent Accounting Pronouncements

In April 2014, the Financial Accounting Standards Board ("FASB") issued an accounting standards update providing new guidance on the requirements for reporting a discontinued operation. The new guidance changes the criteria for reporting discontinued operations and enhances the reporting requirements for discontinued operations. Under the new guidance, a discontinued operation must represent a strategic shift that has or will have a major effect on an entity's operations and financial results. The revised standard will allow an entity to have certain continuing cash flows or involvement with the component after the disposal, and requires expanded disclosures. The standard is effective for reporting periods beginning after December 15, 2014. Management does not anticipate that the adoption of this standard will have a significant impact on the Company's consolidated financial statements.

In May 2014, the FASB issued a comprehensive new standard which amends revenue recognition principles and provides a single set of criteria for revenue recognition among all industries. The new standard provides a five step framework whereby revenue is recognized when promised goods or services are transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires enhanced disclosures pertaining to revenue recognition in both interim and annual periods. The standard is effective for interim and annual periods beginning after December 15, 2016 and allows for adoption using a full retrospective method, or a modified retrospective method. Management has not yet assessed the method of adoption or the expected impact the new standard will have on the Company's consolidated financial statements.

In August 2014, the FASB issued new guidance regarding the Company's responsibility for disclosure of uncertainties about an entity's ability to continue as a going concern. Management will be required to evaluate whether there are conditions and events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the financial statements are issued, and, if so, disclose that fact. Management will be required to make this evaluation for both annual and interim reporting periods, if applicable. The standard is effective for annual periods ending after December 15, 2016 and interim periods ending after December 15, 2016. Management does not anticipate that the adoption of this standard will significantly impact the Company's consolidated financial statements.

The Company does not believe there are any other recent accounting pronouncements that would have a material impact on its financial position or results of operations.

Inflation

Inflationary factors such as increases in the cost of our sales and overhead costs may adversely affect our operating results. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, a high rate of inflation in the future may have an adverse effect on our ability to maintain current levels of gross margin and selling, general and administrative expenses as a percentage of net sales if the selling prices of our products do not increase with these increased costs.

- 20 -

Off-Balance Sheet Arrangements

As of September 30, 2014, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to its stockholders.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not Applicable.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

As of September 30, 2014, the Company’s management, under the direction of its Chief Executive Officer and the Chief Financial Officer, Mr. Sean Macdonald, carried out an evaluation of the effectiveness of the design and operation of the disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in our SEC reports is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms, and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer determined that the Company’s disclosure controls and procedures were deemed to be effective.

Changes in Internal Controls over Financial Reporting

There were no changes in our internal controls over financial reporting during the period ended September 30, 2014, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II
OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

From time to time, we may become involved in various lawsuits and legal proceedings in the ordinary course of our business. Other than as set forth below, we are currently not aware of any legal proceedings the ultimate outcome of which, in our judgment based on information currently available, would have a material adverse affect on our business, financial condition or operating results.

On December 30, 2011, a motorcycle rider brought suit against the Company in the United States District Court for the Northern District of Ohio (Eastern Division) for alleged breach of warranty and product liability claims in connection with injury allegedly suffered by him during an October 2011 accident while wearing one of the Company’s products. The plaintiff is seeking damages in excess of $75,000 for compensatory and punitive damages together with interest and costs of bringing the action. This matter has been settled.
In February 2012, Scott Scarvelli, a motorcycle rider, and his parents, brought suit against the Company in the United States District Court for the Northern District of Ohio (Eastern Division) for alleged breach of warranty and product liability claims. The Scarvellis had alleged that defective product design and failure to warn had caused the then fifteen year-old Scott, to suffer multiple mid-thoracic spine fractures, causing immediate and permanent paraplegia, when he crashed at a relatively low speed on February 13, 2011. When the accident occurred, he was wearing a helmet and other safety gear from several different companies, including the Company's acclaimed Leatt-Brace®. The plaintiffs were seeking damages in excess of $75,000 for compensatory and punitive damages together with interest and costs of bringing the action. However, the Company produced evidence at trial showing that Scott’s thoracic paraplegia was an unavoidable consequence of his fall, not the result of wearing a Leatt-Brace®, and that the neck brace likely saved his life—or saved him from quadriplegia—by preventing cervical spine injury. After a two-week trial ending on April 17, 2014, a federal jury returned a defense verdict for the Company. This matter has been settled.

- 21 -

On July 24, 2012, a motorcycle rider brought suit against the Company in Los Angeles (CA) Superior Court for alleged negligence, strict product liability, breach of expressed and implied warranties in connection with injury allegedly suffered by him during a September 2010 accident while wearing one of the Company’s products. The plaintiff is seeking damages, together with interest and costs of bringing the action. Trial is currently scheduled to commence January 21, 2015. The Company believes that the lawsuit is without merit and will vigorously defend itself.
In September 20, 2012, a lawsuit was filed against the Company and other Defendants in Clark County District Court of Nevada for wrongful death of a motorcycle rider for alleged negligence, product defect, strict product liability, breach of expressed and implied warranties, survival and punitive damages. The plaintiff is seeking special, compensatory, survival and punitive damages, together with prejudgment interest, costs and disbursement of suit, reasonable attorneys’ fees and other relief. Trial is currently scheduled to commence on January 11, 2016. The Company believes that the lawsuit is without merit and will vigorously defend itself.
On December 28, 2012, a lawsuit was filed against the Company in Los Angeles Superior Court for wrongful death of a motorcycle rider. The plaintiffs are seeking damages for wrongful death and other relief. The case was timely removed to federal court. Trial is currently scheduled to commence on May 5, 2015. The Company believes that the lawsuit is without merit and will vigorously defend itself.
In February 2013, a lawsuit was filed against the Company on behalf of a motorcycle rider in Clark County District Court of Nevada for alleged product defect, failure to warn and negligence. The plaintiff is seeking damages, together with interest and costs of bringing the action. Trial is currently scheduled to commence August 3, 2015. The Company believes that the lawsuit is without merit and will vigorously defend itself.

ITEM 1A. RISK FACTORS.

There are no material changes from the risk factors previously disclosed in Item 1A “Risk Factors” of our annual report on Form 10-K for the period ended December 31, 2013.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

We have no information to disclose that was required to be in a report on Form 8-K during the period covered by this report, but was not reported. There have been no material changes to the procedures by which security holders may recommend nominees to our board of directors.

- 22 -

ITEM 6. EXHIBITS.

The following exhibits are filed as part of this report or incorporated by reference:

Exhibit No.	Description
31.1	Certifications of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certifications of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certifications of Principal Executive Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certifications of Principal Financial Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101*	Interactive data files pursuant to Rule 405 of Regulation S-T

Filed with this Form 10-Q for Leatt Corporation. Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections.

- 23 -

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 13, 2014	LEATT CORPORATION


	By: /s/ Sean Macdonald
	Sean Macdonald
	Chief Executive Officer and Chief Financial Officer
	(Principal Executive, Financial and Accounting Officer)

- 24 -

EXHIBIT INDEX

Exhibit No.	Description
31.1	Certifications of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certifications of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certifications of Principal Executive Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certifications of Principal Financial Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101*	Interactive data files pursuant to Rule 405 of Regulation S-T